Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of Simmitecan and Simmitecan, 5-fluorouracil and Leucovorin Calcium, in Patients With Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 18 Jul 2017
At a glance
- Drugs Simmitecan (Primary) ; Fluorouracil; Folinic acid
- Indications Colorectal cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors ShangHai HaiHe Pharmaceutical
- 18 Jul 2017 Number of arms of the study has increased from 4 to 6,hence number of planned patient number has also changed from 153 to243.
- 11 Jul 2017 Planned number of patients changed from 158 to 243.
- 11 Jul 2017 Planned End Date changed from 1 Oct 2018 to 1 Dec 2020.